Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Phase 2 Clinical Trial of E6011 in Patients With Active Crohn's Disease

NCT03733314 is registered in ClinicalTrials.gov with EA Pharma Co., Ltd. as lead sponsor.

NCT NCT03733314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03733314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Phase 2 Clinical Trial of E6011 in Patients With Active Crohn's Disease
Lead sponsor
EA Pharma Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
April 25, 2019
Completion date
April 3, 2024
Enrollment
25 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease